Suchergebnisse - "Badia, Xavier"

PubPharm (233)

1

Incidence and management of patients with methotrexate delayed elimination in the clinical practice : A Delphi study

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2023

von Gros, L. | Roldán, A. | Cabero-Martínez, A. | +9

2

Use of hospital resources in ICU inpatients with infections caused by carbapenem-resistant Gram-negative bacteria : A real clinical practice-based study in Spain

enthalten in: Enfermedades infecciosas y microbiologia clinica (English ed.) | 2023

von Ferrer, R. | Garnacho-Montero, J. | Rascado, P. | +5

3

ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain

enthalten in: Orphanet journal of rare diseases | 2023

von Poveda, J. | Gómez, C. | Gil, A. | +1

4

ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requiring a PASS would be more likely to be reimbursed in Spain

enthalten in: Orphanet journal of rare diseases | 2023

von Poveda, J. | Gómez, C. | Gil, A. | +1

5

ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requiring a PASS would be more likely to be reimbursed in Spain

enthalten in: Orphanet journal of rare diseases | 2023

von Poveda, J. | Gómez, C. | Gil, A. | +1

6

The development and roll-out of a new hydrocoele surgery facility assessment tool for the elimination of lymphatic filariasis

enthalten in: International health | 2022

von Martindale, S. | Mableson, H. | Bodimeade, C. | +16

ErratumIn: Int Health. 2023 Mar 1;15(2):233. - PMID 36538769

7

Contribution of cabotegravir + rilpivirine long-acting for the treatment of HIV-1 infection

enthalten in: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria | 2022

von Calleja-Hernández, M. | Martinez-Sesmero, J. | Vallejo-Aparicio, L. | +2

8

Feasibility study to characterize price and reimbursement decision-making criteria for the inclusion of new drugs in the Spanish National Health System : the cefiderocol example

enthalten in: International journal of technology assessment in health care | 2022

von Calleja, M. | Badia, X.

9

Determining the burden of infectious diseases caused by carbapenem-resistant gram-negative bacteria in Spain

enthalten in: Enfermedades infecciosas y microbiologia clinica (English ed.) | 2021

von Cantón, R. | Huarte, R. | Morata, L. | +5

10

Impact of the therapeutic positioning report in the P&R process in Spain : analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019

enthalten in: Orphanet journal of rare diseases | 2020

von Badia, X. | Vico, T. | Shepherd, J. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[24]